MedPage Today on MSN
Thrombolysis no better than aspirin for central retinal artery occlusion
Vision recovery similar at 30 days, consistent with other recent randomized studies ...
Breakthrough Therapy Designation granted to NXC-201 based on positive NEXICART-2 Phase 2 interim clinical results, presented at the American Society of Hematology (ASH) 2025 annual meeting - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results